Tradestie Institutional Equity Comparison Engine

ABUS vs GMGI โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ABUS Overall Edge

ABUS Captures Institutional Edge (4โ€“0 Pillars ยท 8โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Arbutus Biopharma Corporation Common Stock (ABUS) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, ABUS trades at 10.2x Forward P/E with 80.1% operating margin (-43.5% YoY revenue) versus GMGI at 128.2x Forward P/E and -0.8% operating margin (+15.4% YoY). In options structure, ABUS sits in CONSOLIDATION (18th %ile IV; Dealer Gamma Walls on Pro) against GMGI sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner ABUS
ABUS 10.2x vs GMGI 128.2x Fwd P/E
Growth & Margin Winner ABUS
Op Margin 80.1% vs -0.8% ยท YoY -43.5% vs +15.4%
Momentum & Technical Winner ABUS
1Y -5.8% vs -67.7% ยท 52W Pos 27% vs 9%
Options & Structure Winner ABUS
CONSOLIDATION (18th %ile IV) vs UNCLASSIFIED (N/A IV)
ABUS NASDAQ
Arbutus Biopharma Corporation Common Stock
Pharmaceutical Preparations
$4.02
-1.23% 1D
Market Cap $623.9M
1M Return -4.51%
1Y Return -5.85%
Forward P/E 10.2x
Unified AI Score
43.4 / 100 HOLD
Tech 28.0 Fund 48.0 Flow 68.0 Mom 53.7
GMGI NASDAQ
Golden Matrix Group, Inc. Common Stock
Services-Prepackaged Software
$0.64
+9.86% 1D
Market Cap $81.9M
1M Return -7.45%
1Y Return -67.65%
Forward P/E 128.2x
Unified AI Score
51.1 / 100 HOLD
Tech 60.0 Fund 45.0 Flow 50.0 Mom 38.2

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ABUS -5.85% GMGI -67.65% Spread: +33.79 pp (ABUS Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ABUS TTM Op. Margin: 80.1% GMGI TTM Op. Margin: -0.8%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ABUS vs GMGI. Trailing 12-month operating profitability (ABUS 80.1% vs GMGI -0.8%) and valuation multiples (ABUS 10.2x vs GMGI 128.2x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ABUS (8) vs GMGI (2)
Institutional Metric ABUS GMGI Criterion Row Winner
Market Capitalization Scale $623.9M $81.9M Larger Scale ABUS
Trailing P/E Ratio Valuation 3.6x 128.2x Lower Multiple ABUS
Forward P/E Ratio Valuation 10.2x 128.2x Lower Multiple ABUS
Revenue Growth (YoY) Growth -43.5% +15.4% Higher Growth GMGI
Operating Margin (TTM) Profitability 80.1% -0.8% Higher Margin ABUS
Net Profit Margin Profitability 121.2% -3.0% Higher Margin ABUS
Return on Equity (ROE) Capital Efficiency 269.6% -5.0% Higher ROE ABUS
52-Week Range Position Momentum 27% ($4โ€“$5) 9% ($0โ€“$2) Stronger Trend ABUS
Beta / 30D Volatility Risk Regime 1.04ฮฒ ยท 48% Vol 1.40ฮฒ ยท 117% Vol Lower Realized Risk ABUS
Unified Institutional Score Composite Signal 43.4 / 100 (HOLD) 51.1 / 100 (HOLD) Higher Composite GMGI

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ABUS vs GMGI Buy Guide
ABUS CONSOLIDATION
96d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 18th %ile
IV Regime Compressed (<25th %ile)
Live ABUS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
GMGI UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live GMGI Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ABUS nor GMGI registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.